These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29246912)

  • 1. Outcomes of Saphenous Vein Graft Intervention With and Without Embolic Protection Device: A Comprehensive Review and Meta-Analysis.
    Paul TK; Bhatheja S; Panchal HB; Zheng S; Banerjee S; Rao SV; Guzman L; Beohar N; Zhao D; Mehran R; Mukherjee D
    Circ Cardiovasc Interv; 2017 Dec; 10(12):. PubMed ID: 29246912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embolic protection device use and its association with procedural safety and long-term outcomes following saphenous vein graft intervention: An analysis from the British Columbia Cardiac registry.
    Iqbal MB; Nadra IJ; Ding L; Fung A; Aymong E; Chan AW; Hodge S; Della Siega A; Robinson SD;
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):73-83. PubMed ID: 26482020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embolic protection device use and outcomes in patients receiving saphenous vein graft interventions--a single-center experience.
    Golwala H; Hawkins BM; Stavrakis S; Abu-Fadel MS
    J Invasive Cardiol; 2012 Jan; 24(1):1-3. PubMed ID: 22210580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes Following Percutaneous Coronary Intervention in Saphenous Vein Grafts With and Without Embolic Protection Devices.
    Shoaib A; Kinnaird T; Curzen N; Ludman P; Smith D; Khoo CW; Kontopantelis E; Rashid M; Mohamed M; Nolan J; Zaman A; Mamas MA; ;
    JACC Cardiovasc Interv; 2019 Nov; 12(22):2286-2295. PubMed ID: 31753300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-Eluting Versus Bare Metal Stents in Saphenous Vein Graft Intervention: An Updated Comprehensive Meta-Analysis of Randomized Trials.
    Bhogal S; Panchal HB; Bagai J; Banerjee S; Brilakis ES; Mukherjee D; Kumar G; Shanmugasundaram M; Paul TK
    Cardiovasc Revasc Med; 2019 Sep; 20(9):758-767. PubMed ID: 30503811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug eluting versus bare metal stents for percutaneous coronary intervention of saphenous vein graft lesions: An updated meta-analysis of randomized controlled trials.
    Ha FJ; Nogic J; Montone RA; Cameron JD; Nerlekar N; Brown AJ
    Cardiovasc Revasc Med; 2018; 19(7 Pt B):837-844. PubMed ID: 29685385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.
    Tolerico PH; Cohen DJ; Kleiman NS; Berger PB; Brilakis ES; Piana RN; Shammo S; Keyes MJ; Kennedy KF; Massaro JM; Saucedo JF;
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1127-36. PubMed ID: 22431166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive meta-analysis of randomized controlled trials comparing drug-eluting stents with bare-metal stents in saphenous vein graft interventions.
    Shah R; Jovin IS; Latham SB; Hesterberg K; Heckle MR; Rashid A; Vetrovec GW
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):1229-1236. PubMed ID: 30051628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary Use of Embolic Protection Devices During Saphenous Vein Graft Intervention.
    Valle JA; Glorioso TJ; Schuetze KB; Grunwald GK; Armstrong EJ; Waldo SW
    Circ Cardiovasc Interv; 2019 May; 12(5):e007636. PubMed ID: 31014092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-Eluting Stents Versus Bare-Metal Stents in Saphenous Vein Graft Intervention.
    Patel NJ; Bavishi C; Atti V; Tripathi A; Nalluri N; Cohen MG; Kini AS; Sharma SK; Dangas G; Bhatt DL
    Circ Cardiovasc Interv; 2018 Nov; 11(11):e007045. PubMed ID: 30571204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sealing Intermediate Nonobstructive Coronary Saphenous Vein Graft Lesions With Drug-Eluting Stents as a New Approach to Reducing Cardiac Events: A Randomized Controlled Trial.
    Rodés-Cabau J; Jolly SS; Cairns J; Mansour S; L'Allier PL; Teefy PJ; Graham JJ; Le May MR; Cantor WJ; Wood D; Balasubramanian K; DeLarochellière R; Dzavik V;
    Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27815344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of embolic protection devices in ostial saphenous vein graft lesions.
    Abdel-Karim AR; Papayannis AC; Mahmood A; Michael TT; Rangan BV; Makke L; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1120-6. PubMed ID: 22422709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective use of embolic protection devices during saphenous vein grafts interventions: a single-center experience.
    Lavi S; Ivanov J; Appleby CE; Seidelin PH; Mackie K; Schwartz L; Dzavík V
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):1037-44. PubMed ID: 20517966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The short- and long-term outcomes of percutaneous intervention with drug-eluting stent vs bare-metal stent in saphenous vein graft disease: An updated meta-analysis of all randomized clinical trials.
    Kheiri B; Osman M; Abdalla A; Ahmed S; Bachuwa G; Hassan M
    Clin Cardiol; 2018 May; 41(5):685-692. PubMed ID: 29749621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term follow-up of drug eluting versus bare metal stents in the treatment of saphenous vein graft lesions.
    Ybarra LF; Ribeiro HB; Pozetti AH; Campos CA; Esper RB; Lemos PA; Lopes AC; Kalil-Filho R; Ellis SG; Ribeiro EE
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E856-63. PubMed ID: 23239630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential 1-year clinical outcomes for ST-segment elevation myocardial infarction related to stent thrombosis or saphenous vein graft thrombosis.
    Arzamendi D; Ly HQ; Tanguay JF; Armero S; Jilaihawi H; Gallo R; Ibrahim R; L'Allier P; Blondeau L; Gosselin G; Gregoire J; Doucet S
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):193-200. PubMed ID: 21805615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of the Drug-Eluting Stents vs Bare-Metal Stents in Saphenous Vein Graft Angioplasty (DIVA) Trial.
    Brilakis ES; Banerjee S; Edson R; Shunk K; Goldman S; Holmes DR; Bhatt DL; Rao SV; Smith MW; Sather M; Colling C; Kar B; Nielsen L; Conner T; Wagner T; Rangan BV; Ventura B; Lu Y; Holodniy M; Shih MC
    Clin Cardiol; 2017 Nov; 40(11):946-954. PubMed ID: 28841230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing saphenous vein graft intervention with drug-eluting stents: a multicenter Southern Californian Registry.
    Lee MS; Hu PP; Aragon J; Shah A; Bhatia R; Jones N; Penny W; French W; Tobis J; Mahmud E
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):272-8. PubMed ID: 20623716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial.
    Kereiakes DJ; Turco MA; Breall J; Farhat NZ; Feldman RL; McLaurin B; Popma JJ; Mauri L; Zimetbaum P; Massaro J; Cutlip DE;
    JACC Cardiovasc Interv; 2008 Jun; 1(3):248-57. PubMed ID: 19463308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous Coronary Intervention of Saphenous Vein Graft.
    Redfors B; Généreux P; Witzenbichler B; McAndrew T; Diamond J; Huang X; Maehara A; Weisz G; Mehran R; Kirtane AJ; Stone GW
    Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28495896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.